Events

Recall of MEROCEL SURGICAL PATTIES

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by MEDTRONIC OF CANADA LTD..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    30395
  • Event Risk Class
    II
  • Event Initiated Date
    2017-09-14
  • Event Country
    Canada
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    As part of a notification to all manufacturers of neurosurgical patties medtronic xomed was informed by the food and drug administration's (fda) center for devices and radiological health (cdrh) of a potential postmarket safety concern associated with the use of neurosurgical patty devices. the potential safety concern identified by the fda "is related to clinical consequences when some patties which are designed to be x-ray detectable or radiopaque to assist with post-procedural removal in the event of a missing device are not visible during x-ray imaging." to address this potential concern medtronic is including additional information in the instructions for use regarding these issues to further clarify the use of these devices to health care practitioners. the updated instructions for use includes the precautions that will help reduce the potential for clinical consequences when some neurosurgical patties which are designed to be x ray detectable or radiopaque to assist with post-procedural removal in the event of a missing device are not visible during x-ray imaging.

Device

MEROCEL SURGICAL PATTIES
  • Model / Serial
    Model Catalog: 300507 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 300506 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 300505 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 300503 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 300501 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 80-04009 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 80-04008 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 80-04007 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 80-04006 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 80-04005 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 80-04004 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 80-04003 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 80-04002 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 80-04001 (Lot serial: > 10 lot numbers contact mfg); Model Catalog: 80-04000 (Lot serial: > 10 lot numbers contact mfg); Model Catalog
  • Product Description
    MEROCEL SURGICAL PATTIES;NEURAY SURGICAL PATTIES;NEURAY SURGICAL STRIPS
  • Manufacturer
    MEDTRONIC OF CANADA LTD.

Manufacturer

MEDTRONIC OF CANADA LTD.
  • Manufacturer Address
    BRAMPTON
  • Manufacturer Parent Company (2017)
    Medtronic plc
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    HC